The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evolution of Maternofetal Transport of Immunoglobulins During Human Pregnancy
Malek, A., Sager, R., Kuhn, P., Nicolaides, K. H., & Schneider, H. (1996) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1996.tb00172.x · Cited by 559
Research works printed but not linked: 33
- Shah, 2014, Neonatal sepsis: an old problem with new insights, Virulence, 5, 170, 10.4161/viru.26906 · DOI · Paper page
- Verani, 2010, Group B streptococcal disease in infants: progress in prevention and continued challenges, Clin Perinatol, 37, 375, 10.1016/j.clp.2010.02.002 · DOI
- Cutland, 2009, Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial, Lancet, 374, 1909, 10.1016/S0140-6736(09)61339-8 · DOI
- Thigpen, 2011, Bacterial meningitis in the United States, 1998–2007, N Engl J Med, 364, 2016, 10.1056/NEJMoa1005384 · DOI · Paper page
- Jordan, 2008, Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease a multistate, population-based analysis, Pediatr Infect Dis J, 27, 1057, 10.1097/INF.0b013e318180b3b9 · DOI · Paper page
- Simister, 2003, Placental transport of immunoglobulin G, Vaccine, 21, 3365, 10.1016/S0264-410X(03)00334-7 · DOI · Paper page
- Englund, 2007, The influence of maternal immunization on infant immune responses, J Comp Pathol, 137, S16, 10.1016/j.jcpa.2007.04.006 · DOI · Paper page
- Baker, 1976, Correlation of maternal antibody deficiency with susceptibility to neonatal Group-B Streptococcal infection, N Engl J Med, 294, 753, 10.1056/NEJM197604012941404 · DOI · Paper page
- Lin, 2001, Level of maternal antibody required to protect neonates against early-onset disease caused by group B streptococcus type Ia: a multicenter, seroepidemiology study, J Infect Dis, 184, 1022, 10.1086/323350 · DOI
- Lin, 2004, Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen, J Infect Dis, 190, 928, 10.1086/422756 · DOI
- 2012, Vaccines against influenza WHO position paper—November 2012, Wkly Epidemiol Rec, 87, 461
- Dangor, 2015, Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants, PLoS One, 10, e0123014, 10.1371/journal.pone.0123014 · DOI
- Edmond, 2012, Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis, Lancet, 379, 547, 10.1016/S0140-6736(11)61651-6 · DOI · Paper page
- Madhi, 2013, Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants, Vaccine, 31, D52, 10.1016/j.vaccine.2013.02.029 · DOI
- Madhi, 2003, High burden of invasive Streptococcus agalactiae disease in South African infants, Ann Trop Paediatr, 23, 15, 10.1179/000349803125002814 · DOI
- Leroux-Roels, 2016, A randomized, observer-blind phase Ib study to identify formulations and vaccine schedules of a trivalent group B streptococcus vaccine for use in non-pregnant and pregnant women, Vaccine, 34, 1786, 10.1016/j.vaccine.2016.02.044 · DOI
- Donders, 2016, Maternal immunisation with a trivalent glycoconjugate GBS vaccine—a phase II randomised study, Obstet Gynecol, 127, 213, 10.1097/AOG.0000000000001190 · DOI
- Afshar, 2011, International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci), J Clin Microbiol, 49, 1475, 10.1128/JCM.02365-10 · DOI
- Blencowe, 2012, National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications, Lancet, 379, 2162, 10.1016/S0140-6736(12)60820-4 · DOI · Paper page
- Palmeira, 2012, IgG placental transfer in healthy and pathological pregnancies, Clin Dev Immunol, 2012, 985646, 10.1155/2012/985646 · DOI · Paper page
- Baker, 2003, Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine, Vaccine, 21, 3468, 10.1016/S0264-410X(03)00353-0 · DOI · Paper page
- Heyderman, 2016, Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial, Lancet Infect Dis, 10.1016/S1473-3099(15)00484-3 · DOI
- Andrews, 2014, Serotype-specific effectiveness and correlates of prtoection for the 13-valent pneucoccal conjugate vaccine: a post-licensure indirect cohort study, Lancet Infect Dis, 19, 839, 10.1016/S1473-3099(14)70822-9 · DOI · Paper page
- McIntosh, 2015, Serum bactericidal antibody assays–The role of complement in infection and immunity, Vaccine, 33, 4414, 10.1016/j.vaccine.2015.07.019 · DOI
- Badri, 1977, Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant women, J Infect Dis, 135, 308, 10.1093/infdis/135.2.308 · doi:10.1093/infdis/135.2.308
- Botta, 1979, Hormonal and type-dependent adhesion of group B streptococci to human vaginal cells, Infect Immun, 25, 1084, 10.1128/iai.25.3.1084-1086.1979 · doi:10.1128/iai.25.3.1084-1086.1979
- Hansen, 2004, Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants, J Clin Microbiol, 42, 83, 10.1128/JCM.42.1.83-89.2004 · DOI
- Kwatra, 2015, Natural acquired humoral immunity against serotype-specific group B streptococcus rectovaginal colonization acquisition in pregnant women, Clin Microbiol Infect, 21, 568e13, 10.1016/j.cmi.2015.01.030 · DOI
- Kwatra G, Adrian PV, Shiri T, Cutland CL, Madhi SA. Serotype specific cellular mediated immunity associated with clearance of homotypic group B streptococcus recto-vaginal colonization in pregnant women. J Infect Dis (in press).
- Dangor, 2014, Review on the association of group B streptococcus capsular antibody and protection against invasive disease in infants, Expert Rev Vaccines, 22, 1
- Baker, 2014, Maternal antibody at delivery protects neonates from early onset group B streptococcal disease, J Infect Dis, 209, 781, 10.1093/infdis/jit549 · DOI
- Cutland, 2015, Increased risk for group B streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004–2008, Emerg Infect Dis, 21, 638, 10.3201/eid2104.141562 · DOI
- Cutland, 2015, Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country, Vaccine, 33, 6406, 10.1016/j.vaccine.2015.08.040 · DOI
Cited by
Seale, A. C., Bianchi-Jassir, F., Russell, N. J., Kohli-Lynch, M., Tann, C. J., Hall, J., Madrid, L., Blencowe, H., Cousens, S., Baker, C. J., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix664 · Cited by 511
Self-citationCommunity-acquired bacterial meningitis.
van de Beek, D., Brouwer, M. C., Koedel, U., & Wall, E. C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00883-7 · Cited by 292
Kobayashi, M., Schrag, S. J., Alderson, M. R., Madhi, S. A., Baker, C. J., Sobanjo-ter Meulen, A., Kaslow, D. C., Smith, P. G., Moorthy, V. S., & Vekemans, J. (2019) · Vaccine · doi:10.1016/j.vaccine.2016.12.029 · Cited by 105
Self-citationGiles, M. L., Buttery, J., Davey, M.-A., & Wallace, E. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.08.084 · Cited by 56
Metadata
- Authors
- Madhi, S. A., Cutland, C. L., Jose, L., Koen, A., Govender, N., Wittke, F., Olugbosi, M., Meulen, A. S.-T., Baker, S., Dull, P. M., Narasimhan, V., & Slobod, K.
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 16
- Issue
- 8
- Pages
- 923-934
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W2342773131
- Cited by
- 165
- References
- 1
- FWCI
- 25.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. https://app.cochat.ai/papers/10.1016/s1473-3099(16)00152-3
- The paper
- Madhi, S. A., Cutland, C. L., Jose, L., Koen, A., Govender, N., Wittke, F., Olugbosi, M., Meulen, A. S.-T., Baker, S., Dull, P. M., Narasimhan, V., & Slobod, K. (2016). Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(16)00152-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.